NEONC TECHNOLOGIES HOLDINGS, INC. 8-K

What Happened

• NEONC Technologies Holdings, Inc. (NTHI) filed an 8-K (Apr 24, 2026) disclosing a series of private placements under Securities Purchase Agreements to sell up to 2,222,222 shares of common stock and five‑year warrants to purchase the same number of shares.
• Across four purchase agreements and multiple closings the company issued approximately 2,093,305 shares (with matching five‑year warrants) for aggregate gross proceeds of roughly $15.07 million. Key closings include: an initial institutional placement of 1,388,888 shares and warrants for $10.0M (offering terminated Jan 31, 2026); additional closings on Feb 25, 2026 (201,390 shares/warrants, $1.45M) and Mar 20, 2026 (138,889 shares/warrants, $1.0M); and an Apr 20, 2026 closing (277,777 shares/warrants, ≈$2.0M). The per‑share purchase price was $7.20; each warrant has a $9.00 exercise price.

Key Details

• Securities: Common stock at $7.20 per share and five‑year warrants exercisable at $9.00 per share.
• Shares/warrants issued in reported closings: ~2,093,305 shares and matching warrants for ~ $15.07M in gross proceeds.
• Use of proceeds: Company intends to use net proceeds to fund NEO216 preclinical trials.
• Regulation: Securities sold in private placements under Section 4(a)(2) of the Securities Act; for the fourth agreement the company will file a resale registration statement for the shares and warrant shares no later than 10 days after that initial closing.

Why It Matters

• This is a capital raise to fund the company’s NEO216 preclinical program — a clear use of proceeds that affects near‑term liquidity and clinical funding plans.
• The financings dilute existing shareholders (new shares issued plus potential warrant exercises) and set a reference price ($7.20) and a $9.00 strike on warrants that could lead to future share issuance if exercised.
• The transactions were private (unregistered) placements, but the company plans a resale registration for the fourth-closing securities, which could enable secondary market liquidity for those shares/warrant shares once declared effective.